Oct 23rd, 2013 – Light Age Inc., a Somerset, NJ based developer and manufacturer of advanced laser systems announces the signing of a nationwide representation and distribution agreement with Moore Medical LLC to sell the QClear Compact Laser System.

This increases the distribution and offering of this product to US Physicians, Podiatrists, Dermatologists, and Plastic Surgeons. Together, they expect also to reach organizations supporting Corrections facilities, the Veterans Administration, Indian Health Services, and others.

Delivering both 1064 nm and 532 nm, the Q-Clear Laser System has been cleared by the US FDA for the treatment of patients with onchomycosis (toenail fungus).  the Q–Clear has been cleared by the US FDA since 2004 for more than two dozen indications including the removal of tattoos, vascular, and pigmented lesions.  The Q-Clear provides revolutionary, minimally invasive, and highly effective laser treatments.  Weighing in at just 35 pounds, it is portable and an affordable solution for the practitioner.

The Q Clear Laser System is a breakthrough in the treatment of nail fungus. In many cases, relief is achieved in as little as one session. Estimates are that more than 10% of the US population suffers symptoms of this ailment. Moore Medical LLC, a subsidiary of McKesson Medical-Surgical, is an Internet-enabled, multi-channel, specialty direct marketer and distributor of medical-surgical supplies, equipment and pharmaceuticals to approximately 120,000 healthcare practices, facilities and organizations in non-hospital settings nationwide. See www.mooremedical.com

“This is a great opportunity for both Light Age, Inc. and Moore Medical, LLC to provide our innovative Q-Clear to more practices nationwide, through the already established Moore Medical distribution network. That gives a great opportunity to more doctors to experience the best laser for treating Onychonycosis and other indications. As the clinical study submitted to the US FDA states: Statistical analysis of results indicates significant apparent clearing in 95% of the subjects with an average clearance of affected areas of 56±7% at 98% level of confidence. The protocol employed was extremely well tolerated by patients, no pain was reported, although some patients reported feeling a low-level sensation on some involved toenails.”

Says George Georgitsis, Director of Marketing at Light Age, Inc.

About Light Age, Inc.

Light Age, Inc. is a privately held US corporation, with principal offices in New Jersey. Born from a tradition of Scientific advancements, while focusing on the creation of innovative products that serve human needs, Light Age serves the global healthcare and aesthetic markets with industry leading Alexandrite and Nd:YAG laser systems. For more information contact Light Age’s sales or marketing department at 732-563-0600 or email us at sales@192.163.194.50, marketing@192.163.194.50 We are on the web at http://www.lightage.com